BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Cardiva Medical, Inc. Appoints Two New Officers


1/17/2008 7:01:25 AM

MOUNTAIN VIEW, Calif., Jan. 17 /PRNewswire/ -- Cardiva Medical, Inc., a privately held medical device company and developer of the Boomerang Catalyst(TM) System is pleased to announce the addition of two officers to their management team. Malcolm Farnsworth joins Cardiva as Vice President of Finance and Chief Financial Officer. Tara Zerby joins Cardiva as Vice President of Business Development and Marketing.

"We are very excited to have Malcolm and Tara join Cardiva during this exciting stage in the company," says Augustine Lien, Chairman and CEO. "Their expertise in the medical device industry will be beneficial in the growth of our company."

Malcolm Farnsworth joined Cardiva in January 2008. Previously, Mr. Farnsworth served as Executive Vice President and Chief Financial Officer at POINT Biomedical Corporation, a specialty pharmaceutical company developing pharmaceutical imaging agents to detect coronary artery disease. Prior to that, he served as Vice President of Finance and Chief Financial Officer at Gynecare, Inc., a medical device company, that was acquired by Johnson & Johnson after its IPO in 1996. Before that he served as Vice President of Finance and Chief Financial Officer at Origin Medsystems, a minimally invasive surgical device company that was acquired by Eli Lilly and merged into Guidant. Mr. Farnsworth holds an M.B.A. degree from the Haas School, University of California at Berkeley and a B.S. degree in Business and Economics from Lehigh University.

Tara L. Zerby joined Cardiva in November 2007. Ms. Zerby brings with her over 25 years of experience in sales, marketing and management in the medical device industry. Prior to joining Cardiva, she served as Vice President and General Manager of RTI-Cardiovascular, formerly the Alabama Tissue Center. Ms. Zerby operated her own consulting firm, assisting start-up medical device companies. She was also the executive Director of Marketing and Clinical Applications for Stereotaxis, Inc., Business Unit Director, Surgical Systems and Director of Global Sales for Cryocath Technologies. Ms. Zerby holds an M.B.A. from University of Wisconsin, an M.A. from Georgia State and a B.A. from Wake Forest.

About Cardiva Medical, Inc.

Founded in July 2002, and headquartered in Mountain View, Calif., Cardiva Medical, Inc. is a privately held medical company focused on developing and commercializing vascular access site management and closure devices with unsurpassed safety and ease-of-use. Cardiva's first product, the Boomerang Wire System, was approved in EU countries and in the US in 2004. Cardiva's second-generation product, the Boomerang Catalyst System, was approved in March 2007 and launched in July 2007. The enhanced Boomerang Catalyst, trade named as "Boomerang Catalyst II System" received 510(K) clearance in September 2007 and launched in January 2008. Cardiva was selected by Frost & Sullivan as the recipient of the 2006 Frost & Sullivan Award for Entrepreneurial Company in the U.S. angioplasty and vascular closure devices market. For additional information about Cardiva Medical, Inc. see our website at http://www.cardivamedical.com.

Cardiva, Boomerang and Boomerang Catalyst System are trademarks/registered trademarks of Cardiva Medical, Inc.

glenn_foy@cardivamedical.com

CONTACT: Glenn Foy, President of Cardiva Medical, Inc., +1-650-964-8900
ext. 215, Fax, +1-650-964-8911, glenn_foy@cardivamedical.com

Web site: http://www.cardivamedical.com/



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES